(Q54659066)

2 June 2018

title

Ezetimibe decreases SREBP-1c expression in liver and reverses hepatic insulin resistance in mice fed a high-fat diet (English)

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

14 June 2024

1 reference

1 reference

6

Hiroyuki Aburatani

1 reference

2 June 2018

author name string

Tomonori Muraoka

1

1 reference

2 June 2018

Kazutaka Aoki

2

1 reference

2 June 2018

Tomoyuki Iwasaki

3

1 reference

2 June 2018

Kazuaki Shinoda

4

1 reference

2 June 2018

Akinobu Nakamura

5

1 reference

2 June 2018

Shuuichi Mori

7

1 reference

2 June 2018

Kumpei Tokuyama

8

1 reference

2 June 2018

Naoto Kubota

9

1 reference

2 June 2018

Takashi Kadowaki

10

1 reference

2 June 2018

Yasuo Terauchi

11

1 reference

2 June 2018

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20673929

14 June 2024

publication date

2 August 2010

1 reference

2 June 2018

full work available at URL

https://api.elsevier.com/content/article/PII:S0026049510001885?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

https://api.elsevier.com/content/article/PII:S0026049510001885?httpAccept=text/plain

14 June 2024

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

14 June 2024

1 reference

2 June 2018

volume

60

1 reference

2 June 2018

issue

5

1 reference

2 June 2018

page(s)

617-628

1 reference

2 June 2018

Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia.

14 June 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Inhibiting intestinal NPC1L1 activity prevents diet-induced increase in biliary cholesterol in Golden Syrian hamsters.

14 June 2024

3

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome

14 June 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice

14 June 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver disease

14 June 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Ezetimibe improves high fat and cholesterol diet-induced non-alcoholic fatty liver disease in mice

14 June 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Effect of ezetimibe on insulin sensitivity and lipid profile in obese and dyslipidaemic patients

14 June 2024

10

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Ezetimibe, a potent cholesterol absorption inhibitor, inhibits the development of atherosclerosis in ApoE knockout mice

14 June 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

A simple method for the isolation and purification of total lipides from animal tissues

14 June 2024

12

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Serum cholesterol-decreasing effect of heat-moisture-treated high-amylose cornstarch in cholesterol-loaded rats

14 June 2024

14

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance.

14 June 2024

15

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Role of the liver in glucose homeostasis in PI 3-kinase p85alpha-deficient mice

14 June 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Pioglitazone ameliorates insulin resistance and diabetes by both adiponectin-dependent and -independent pathways

14 June 2024

17

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Both insulin signaling defects in the liver and obesity contribute to insulin resistance and cause diabetes in Irs2(-/-) mice

14 June 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus

14 June 2024

19

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study

14 June 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Incorporation of radioactive amino acids into protein in isolated rat hepatocytes

14 June 2024

21

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

The direct effect of dopamine on glucose release from primary cultured rat hepatocytes

14 June 2024

22

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA.

14 June 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Insulin resistance in the GK rat: decreased receptor number but normal kinase activity in liver

14 June 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

RNA interference targeting Fas protects mice from fulminant hepatitis

14 June 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

RNA interference in adult mice.

14 June 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Efficient delivery of siRNA for inhibition of gene expression in postnatal mice

14 June 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Bile acids lower triglyceride levels via a pathway involving FXR, SHP, and SREBP-1c

14 June 2024

28

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

SREBPs suppress IRS-2-mediated insulin signalling in the liver

14 June 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Bile acids regulate gluconeogenic gene expression via small heterodimer partner-mediated repression of hepatocyte nuclear factor 4 and Foxo1.

14 June 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Regulation of SREBP1c gene expression in skeletal muscle: role of retinoid X receptor/liver X receptor and forkhead-O1 transcription factor.

14 June 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

A regulatory cascade of the nuclear receptors FXR, SHP-1, and LRH-1 represses bile acid biosynthesis

14 June 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Molecular basis for feedback regulation of bile acid synthesis by nuclear receptors

14 June 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

14 June 2024

Bile acid biosynthesis

34

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Delineation of molecular changes in intrahepatic cholesterol metabolism resulting from diminished cholesterol absorption

14 June 2024

35

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Ezetimibe ameliorates cholecystosteatosis.

14 June 2024

36

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

Cholesterol absorption efficiency regulates plasma cholesterol level in the Finnish population

14 June 2024

38

1 reference

https://api.crossref.org/works/10.1016/J.METABOL.2010.06.008

14 June 2024

Identifiers

1 reference

2 June 2018

1 reference

2 June 2018